This paper is only available as a PDF. To read, Please Download here.
Abstract
Effective treatment of female androgenetic alopecia involves cessation of hair shedding
and promotion of normal anagen hair growth. The topical use of hormones such as progesterone
or an androgen receptor-binding drug such as spironolactone has not been associated
with significant hair regrowth.1 In contrast, the topical use of minoxidil has resulted in decreased hair shedding
and hair growth promotion, particularly in men with androgenetic alopecia.2 To investigate the usefulness of topical minoxidil therapy in female androgenetic
alopecia, we studied the efficacy and safety of 3% topical minoxidil in 25 affected
women. Results were correlated with disease extent and activity.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Clinics in DermatologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Androgenetic alopecia.in: Thiers BH Dobson RL Pathogenesis of Skin Disease. Churchill Livingstone, New York1986: 41-55
- Use of topical minoxidil in the treatment of male pattern baldness.J Am Acad dermatol. 1987; 16: 696-704
- Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex.Br J dermatol. 1977; 97: 247-264
- Common baldness in women.Int J dermatol. 1981; 20: 647-650
- Androgenic alopecia.Dermatol Clin. 1987; 5: 491-500
- Treatment of female androgenetic alopecia with cimetidine.Int J dermatol. 1987; 26: 128-130
Article info
Identification
Copyright
© 1988 Published by Elsevier Inc.
